Managers / Q3 2021 · view latest →
EXANE DERIVATIVES
CIK 0001623883 · 6 RUE MENARS, PARIS, I0, 75002 · 33 1 44 95 40 00
Reported Value
$416.5B
Q3 2021
Positions
1,046
Filings on Record
16
2019–present window
Filed
Oct 26, 2021
original filing
Summary
Exane Derivatives reported $416.5B in U.S.-listed holdings across 1,046 positions for Q3 2021.
Its largest position, Ubs, represents 6.3% of the portfolio.
Compared with Q2 2021, the fund opened 62 new positions and exited 53.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q3 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2022 | $174.0B | 758 | Jul 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $355.1B | 1,021 | Apr 22, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $413.3B | 890 | Jan 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $416.5B | 1,046 | Oct 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $441.0B | 1,054 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $349.8B | 894 | Apr 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $340.0B | 838 | Jan 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $345.3B | 754 | Oct 8, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2020 | $374.2B | 687 | Jul 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $357.9B | 702 | Apr 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $539.7B | 684 | Jan 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $557.6B | 654 | Oct 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $570.5B | 668 | Jul 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $505.8B | 637 | Apr 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $557.3B | 674 | Jan 31, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.